Cargando…
EpCAM-independent isolation of circulating tumor cells with epithelial-to-mesenchymal transition and cancer stem cell phenotypes using ApoStream(®) in patients with breast cancer treated with primary systemic therapy
BACKGROUND: Tumor cells with a mesenchymal phenotype and/or cancer stem-like cells (CSCs) are known to contribute to metastasis and drug resistance. Circulating tumor cells (CTCs) undergoing epithelial-mesenchymal transition (EMT) and CTCs reflecting a dedifferentiated CSC phenotype may not be detec...
Autores principales: | Le Du, Fanny, Fujii, Takeo, Kida, Kumiko, Davis, Darren W., Park, Minjeong, Liu, Diane D., Wu, Weiguo, Chavez-MacGregor, Mariana, Barcenas, Carlos H., Valero, Vicente, Tripathy, Debu, Reuben, James M., Ueno, Naoto T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098555/ https://www.ncbi.nlm.nih.gov/pubmed/32214335 http://dx.doi.org/10.1371/journal.pone.0229903 |
Ejemplares similares
-
The detection of EpCAM(+) and EpCAM(–) circulating tumor cells
por: Wit, Sanne de, et al.
Publicado: (2015) -
Expression of EpCAM(MF) and EpCAM(MT) variants in human carcinomas
por: Fong, Dominic, et al.
Publicado: (2014) -
Antibody-independent capture of circulating tumor cells of non-epithelial origin with the ApoStream(®) system
por: Balasubramanian, Priya, et al.
Publicado: (2017) -
Expression of EpCAM in uveal melanoma
por: Odashiro, Danilo N, et al.
Publicado: (2006) -
Biology and clinical relevance of EpCAM
por: Keller, Laura, et al.
Publicado: (2019)